(Q38119922)

English

Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA.

scientific article published on 06 July 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA. (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

1 reference

based on heuristic

inferred from title

synovial sarcoma

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Nico van Zandwijk

4

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

5

object named as

Sonja Klebe

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

author name string

Douglas W Henderson

1

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Steven C Kao

3

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

language of work or name

0 references

publication date

6 July 2013

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Journal of Clinical Pathology

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

66

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

854-861

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

The histology and immunohistochemistry of small cell mesothelioma

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Pleomorphic epithelioid diffuse malignant pleural mesothelioma: a clinicopathological review and conceptual proposal to reclassify as biphasic or sarcomatoid mesothelioma

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Lymphohistiocytoid mesothelioma: a rare lymphomatoid variant of predominantly sarcomatoid mesothelioma

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Lymphohistiocytoid mesothelioma: a clinical, immunohistochemical and ultrastructural study of four cases and literature review.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Lymphohistiocytoid variant of malignant mesothelioma of the pleura: a series of 22 cases.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Desmoplastic malignant mesothelioma: a review of 17 cases

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

The diagnosis of desmoplastic malignant mesothelioma and its distinction from fibrous pleurisy: a histologic and immunohistochemical analysis of 31 cases including p53 immunostaining

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

The fake fat phenomenon in organizing pleuritis: a source of confusion with desmoplastic malignant mesotheliomas

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Bony metastases in desmoplastic pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Primary synovial sarcoma of the lung: report of two cases confirmed by molecular detection of SYT-SSX fusion gene transcripts

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Primary synovial sarcomas of the mediastinum: a clinicopathologic, immunohistochemical, and ultrastructural study of 15 cases

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Primary pulmonary and mediastinal synovial sarcoma: a clinicopathologic study of 60 cases and comparison with five prior series.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Synovial sarcoma of the heart

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Synovial sarcoma and malignant mesothelioma of the pleura: review, differential diagnosis and possible role of apoptosis

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Synovial sarcoma of the pleura: a clinical and pathologic study of three cases.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Synovial sarcoma: an immunohistochemical and ultrastructural study

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Identification of two alternative fusion genes, SYT-SSX1 and SYT-SSX2, in t(X; 18)(p11.2;q11.2)-positive synoviaol sarcomas

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

The SYT protein involved in the t(X;18) synovial sarcoma translocation is a transcriptional activator localised in nuclear bodies

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Nuclear localization of SYT, SSX and the synovial sarcoma-associated SYT-SSX fusion proteins

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

A conditional mouse model of synovial sarcoma: insights into a myogenic origin

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Modeling synovial sarcoma: timing is everything.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Synovial sarcoma: from genetics to genetic-based animal modeling

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

From the archives of the AFIP: Pleuropulmonary synovial sarcoma

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Detection of SS18-SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcoma.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Detection of SYT-SSX fusion transcripts in synovial sarcoma by reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Malignant mesothelioma with heterologous elements: clinicopathological correlation of 27 cases and literature review

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Tumours associated with BAP1 mutations.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Germline mutations in BAP1 predispose to melanocytic tumors

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Frequent mutation of BAP1 in metastasizing uveal melanomas

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Germline BAP1 mutations predispose to malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

The aquaporin family of molecular water channels

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Aquaporin water channels in mammals

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Pathophysiology of the aquaporin water channels

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Physiological importance of aquaporin water channels

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Lung edema clearance: 20 years of progress: invited review: role of aquaporin water channels in fluid transport in lung and airways

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Aquaporin-1 water channel protein in lung: ontogeny, steroid-induced expression, and distribution in rat.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Role of aquaporin and sodium channel in pleural water movement

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Early stages of mesothelioma, screening and biomarkers

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Gene expression profile of aquaporin 1 and associated interactors in malignant pleural mesothelioma.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Water channel (aquaporin 1) expression and distribution in mammary carcinomas and glioblastomas

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Expression of the aquaporin-1 water channel in human glial tumors

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Aquaporin 1 is overexpressed in lung cancer and stimulates NIH-3T3 cell proliferation and anchorage-independent growth

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Aquaporins--new players in cancer biology

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Impairment of angiogenesis and cell migration by targeted aquaporin-1 gene disruption.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Increased migration and metastatic potential of tumor cells expressing aquaporin water channels

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Tetraethylammonium block of water flux in Aquaporin-1 channels expressed in kidney thin limbs of Henle's loop and a kidney-derived cell line

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Pro-tumorigenic effects of miR-31 loss in mesothelioma

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

A Diagnostic Assay Based on MicroRNA Expression Accurately Identifies Malignant Pleural Mesothelioma

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Circulating microRNAs: Association with disease and potential use as biomarkers

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Association of MiR-126 with soluble mesothelin-related peptides, a marker for malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Increased circulating miR-625-3p: a potential biomarker for patients with malignant pleural mesothelioma.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Survival patterns for malignant mesothelioma: the SEER experience

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Inst

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Symptoms and patient-reported well-being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pl

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Prognostic factors in malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Molecular prognostic markers in malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

PTEN expression is a strong predictor of survival in mesothelioma patients

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Using Gene Expression Ratios to Predict Outcome Among Patients With Mesothelioma

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Validation of genomics-based prognostic tests in malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Four-gene expression ratio test for survival in patients undergoing surgery for mesothelioma

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Low calretinin expression and high neutrophil-to-lymphocyte ratio are poor prognostic factors in patients with malignant mesothelioma undergoing extrapleural pneumonectomy.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Exploratory analysis of activation of PTEN-PI3K pathway and downstream proteins in malignant pleural mesothelioma (MPM).

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Inflammation-based prognostic indices in malignant pleural mesothelioma.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases Board

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Toward an Improved Definition of the Tumor Spectrum Associated WithBAP1Germline Mutations

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201609

21 January 2018

Identifiers

10.1136/JCLINPATH-2013-201609

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38119922&oldid=2105507931"